Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 65, Issue 2, 2007, Pages 163-174

  Engstrom, Josh D ^a   Simpson, Dale T ^a   Cloonan, Carrie ^a   Lai, Edwina S ^a   Williams III, Robert O ^b   Barrie Kitto, G ^b   Johnston, Keith P ^a  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Atomization; Gas liquid interface; Lactate dehydrogenase (LDH); Spray freeze drying (SFD); Spray freezing into liquid (SFL)

Indexed keywords

LACTATE DEHYDROGENASE; LIQUID NITROGEN;

ARTICLE; CONTROLLED RELEASE FORMULATION; ENCAPSULATION; ENZYME ACTIVITY; ENZYME RECONSTITUTION; FREEZE DRYING; SPRAY DRYING;

ANIMALS; CATALYSIS; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; FREEZE DRYING; FREEZING; HUMIDITY; L-LACTATE DEHYDROGENASE; MICROSCOPY, ELECTRON, SCANNING; MYOCARDIUM; NANOPARTICLES; NITROGEN; POWDERS; SURFACE PROPERTIES; SWINE;

EID: 33845940465     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.08.002     Document Type: Article

References (56)

1. Carpenter J.F., Chang B.S., Garzon-Rodriguez W., and Randolph T.W. Rational design of stable lyophilized protein formulations: theory and practice. In: Carpenter John F., and Manning Mark C. (Eds). Pharmaceutical Biotechnology. 13. Rational Design of Stable Protein Formulations (2002), Kluwer, Academic/Plenum Press, New York 109-133
2. Manning M.C., Patel K., and Borchardt R.T. Stability of protein pharmaceuticals. Pharm. Res. 6 (1989) 903-918
3. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 203 (2000) 1-60
4. DePaz R.A., Dale D.A., Barnett C.C., Carpenter J.F., Gaertner A.L., and Randolph T.W. Effects of drying methods and additives on the structure, function, and storage stability of subtilisin: role of protein conformation and molecular mobility. Enzyme Microb. Technol. 31 (2002) 765-774
5. Maa Y.-F., and Costantino H.R. Spray freeze-drying of biopharmaceuticals: applications and stability considerations. In: Costantino H.R., and Pikal M.J. (Eds). Biotechnology: Pharmaceutical Aspects. 2. Lyophilization of Biopharmaceuticals (2004), American Association of Pharmaceutical Scientists, Arlington 519-561
6. Pikal M.J. Mechanisms of protein stabilization during freeze-drying and storage: the relative importance of thermodynamic stabilization and glassy state relaxation dynamics. Drugs Pharm. Sci. 137 (2004) 63-107
7. Maa Y.-F., Zhao L., Payne L.G., and Chen D. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application. J. Pharm. Sci. 92 (2003) 319-332
8. Lam X.M., Duenas E.T., Daugherty A.L., Levin N., and Cleland J.L. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J. Controll. Release 67 (2000) 281-292
9. Leach W.T., Simpson D.T., Val T.N., Anuta E.C., Yu Z., Williams III R.O., and Johnston K.P. Uniform encapsulation of stable protein nanoparticles produced by spray freezing for the reduction of burst release. J. Pharm. Sci. 94 (2005) 56-69
10. Johnson O.L., Jaworowicz W., Cleland J.L., Bailey L., Charnis M., Duenas E., Wu C., Shepard D., Magil S., Last T., Jones A.J.S., and Putney S.D. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 14 (1997) 730-735
11. Lam X.M., Duenas E.T., and Cleland J.L. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. J. Pharm. Sci. 90 (2001) 1356-1365
12. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 581-587
13. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M.L., Mintzes J., Deaver D., Lotan N., and Langer R. Large porous particles for pulmonary drug delivery. Science 276 (1997) 1868-1871
14. Shire S.J., Shahrokh Z., and Liu J. Challenges in the development of high protein concentration formulations. J. Pharm. Sci. 93 (2004) 1390-1402
15. Costantino H.R., Johnson O.L., and Zale S.E. Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres. J. Pharm. Sci. 93 (2004) 2624-2634
16. Cleland J.L., Duenas E.T., Park A., Daugherty A., Kahn J., Kowalski J., and Cuthbertson A. Development of poly-(d,l-lactide-co-glycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J. Controll. Release 72 (2001) 13-24
17. Leach W.T., Simpson D.T., Val T.N., Yu Z., Lim K.T., Park E.J., Williams III R.O., and Johnston K.P. Encapsulation of protein nanoparticles into uniform-sized microspheres formed in a spinning oil film. AAPS Pharm. Sci. Tech. 6 (2005) 605-617
18. Costantino H.R., Firouzabadian L., Hogeland K., Wu C.C., Beganski C., Carrasquillo K.G., Cordova M., Griebenow K., Zale S.E., and Tracy M.A. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability. Pharm. Res. 17 (2000) 1374-1383
19. Webb S.D., Golledge S.L., Cleland J.L., Carpenter J.F., and Randolph T.W. Surface adsorption of recombinant human interferon-γ in lyophilized and spray-lyophilized formulations. J. Pharm. Sci. 91 (2002) 1474-1487
20. Maa Y.-F., and Prestrelski S.J. Biopharmaceutical powders: particle formation and formulation considerations. Curr. Pharm. Biotechnol. 1 (2000) 283-302
21. Nguyen X.C., Herberger J.D., and Burke P.A. Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa. Pharm. Res. 21 (2004) 507-514
22. Maa Y.-F., Nguyen P.-A., Sweeney T., Shire S.J., and Hsu C.C. Protein inhalation powders: spray drying vs spray freeze drying. Pharm. Res. 16 (1999) 249-254
23. Adler M., and Lee G. Stability and surface activity of lactate dehydrogenase in spray-dried trehalose. J. Pharm. Sci. 88 (1999) 199-208
24. Sellers S.P., Clark G.S., Sievers R.E., and Carpenter J.F. Dry powders of stable protein formulations from aqueous solutions prepared using supercritical CO(2)-assisted aerosolization. J. Pharm. Sci. 90 (2001) 785-797
25. Yu Z., Rogers T.L., Hu J., Johnston K.P., and Williams III R.O. Preparation and characterization of microparticles containing peptide produced by a novel process: spray freezing into liquid. Eur. J. Pharm. Biopharm. 54 (2002) 221-228
26. Yu Z., Johnston K.P., and Williams III R.O. Spray freezing into liquid versus spray-freeze drying: Influence of atomization on protein aggregation and biological activity. Eur. J. Pharm. Sci. 27 (2006) 9-18
27. Yu Z., Garcia A.S., Johnston K.P., and Williams III R.O. Spray freezing into liquid nitrogen for highly stable protein nanostructured microparticles. Eur. J. Pharm. Biopharm. 58 (2004) 529-537
28. Heller M.C., Carpenter J.F., and Randolph T.W. Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. Biotechnol. Bioeng. 63 (1999) 166-174
29. Akers M.J., Vasudevan V., and Stickelmeyer M. Formulation development of protein dosage forms. In: Nail S.L., and Akers M.J. (Eds). Pharmaceutical Biotechnology. 14. Development and Manufacture of Protein Pharmaceuticals (2002), Kluwer, Academic/Plenum Press, New York 47-127
30. O'Connor T.F., Debenedetti P.G., and Carbeck J.D. Simultaneous determination of structural and thermodynamic effects of carbohydrate solutes on the thermal stability of ribonuclease A. J. Am. Chem. Soc. 126 (2004) 11794-11795
31. Angell C.A., and Wang L.-M. Hyperquenching and cold equilibration strategies for the study of liquid-liquid and protein folding transitions. Biophys. Chem. 105 (2003) 621-637
32. Andya J.D., Maa Y.-F., Costantino H.R., Nguyen P.-A., Dasovich N., Sweeney T.D., Hsu C.C., and Shire S.J. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharm. Res. 16 (1999) 350-358
33. Y.-F. Maa, P.-A. Nguyen, Method of spray freeze drying proteins for pharmaceutical administration, U.S. Patent, 6,284,282, 2001.
34. Costantino H.R., Firouzabadian L., Wu C.C., Carrasquillo K.G., Griebenow K., Zale S.E., and Tracy M.A. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J. Pharm. Sci. 91 (2002) 388-395
35. Chang Z.H., and Baust J.G. Ultra-rapid freezing by spraying/plunging: pre-cooling in the cold gaseous layer. J. Microsc. 161 (1991) 435-444
36. Magdassi S., and Kamyshny A. Surface activity and functional properties of proteins. In: Magdassi S. (Ed). Surface Activity of Proteins (1996), Marcel Dekker, New York 1-38
37. Hu J., Rogers T.L., Brown J., Young T., Johnston K.P., and Williams III R.O. Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology. Pharm. Res. 19 (2002) 1278-1284
38. Hu J., Johnston K.P., and Williams III R.O. Rapid dissolving high potency danazol powders produced by spray freezing into liquid process. Int. J. Pharm. 271 (2004) 145-154
39. Rogers T.L., Hu J., Yu Z., Johnston K.P., and Williams III R.O. A novel particle engineering technology: spray-freezing into liquid. Int. J. Pharm. 242 (2002) 93-100
40. Rogers T.L., Nelsen A.C., Hu J., Brown J.N., Sarkari M., Young T.J., Johnston K.P., and Williams III R.O. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur. J. Pharm. Biopharm. 54 (2002) 271-280
41. Anchordoquy T.J., Izutsu K.-I., Randolph T.W., and Carpenter J.F. Maintenance of quaternary structure in the frozen state stabilizes lactate dehydrogenase during freeze-drying. Arch. Biochem. Biophys. 390 (2001) 35-41
42. Anchordoquy T.J., and Carpenter J.F. Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state. Arch. Biochem. Biophys. 332 (1996) 231-238
43. Carpenter J.F., Izutsu K.-i., and Randolph T.W. Freezing- and drying-induced perturbations of protein structure and mechanisms of protein protection by stabilizing additives. In: Rey L., and May J.C. (Eds). Drugs and the Pharmaceutical Sciences. 137. Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products (2004), Marcel Dekker, New York 147-186
44. C. Sonner, PhD Thesis, University of Erlangen-Nuremburg, 2002.
45. Dams T., Ostendorp R., Ott M., Rutkat K., and Jaenicke R. Tetrameric and octameric lactate dehydrogenase from the hyperthermophilic bacterium thermotoga maritima: structure and stability of the two active forms. Eur. J. Biochem. 240 (1996) 274-279
46. Holbrook J.J., Liljas A., Steindel S.J., and Rossmann M.G. Lactate dehydrogenase. In: Boyer P.D. (Ed). Enzymes. 3rd ed. (1975), Academic Press, New York 191-292
47. J.D. Engstrom, D.T. Simpson, E. Lai, R.O. Williams III, K.P. Johnston, Morphology of protein particles produced by spray freezing of concentrated, Eur. J. Pharm. Biopharm., in press.
48. Brunauer S., Emmett P.H., and Teller E. Adsorption of gases in multimolecular layers. J. Am. Chem. Soc. 60 (1938) 309-319
49. Lengsfeld C.S., Delplanque J.P., Barocas V.H., and Randolph T.W. Mechanism governing microparticle morphology during precipitation by a compressed antisolvent: atomization vs. nucleation and growth. J. Phys. Chem. B 104 (2000) 2725-2735
50. Sitte H., Edelmann L., and Neumann K. Cryofixation without pretreatment at ambient pressure. In: Steinbrecht R.A., and Zierold K. (Eds). Cryotechniques in Biological Electron Microscopy (1987), Springer-Verlag, Berlin 87-113
51. Pikal-Cleland K.A., and Carpenter J.F. Lyophilization-induced protein denaturation in phosphate buffer systems: monomeric and tetrameric β-galactosidase. J. Pharm. Sci. 90 (2001) 1255-1268
52. Bhatnagar B.S., Nehm S.J., Pikal M.J., and Bogner R.H. Post-thaw aging affects activity of lactate dehydrogenase. J. Pharm. Sci. 94 (2005) 1382-1388
53. Carpenter J.F., and Crowe J.H. The mechanism of cryoprotection of proteins by solutes. Cryobiology 25 (1988) 244-255
54. Timasheff S.N. The control of protein stability and association by weak interactions with water: how do solvents affect these processes?. Annu. Rev. Biophys. Biomol. Struct. 22 (1993) 67-97
55. Chang B.S., Kendrick B.S., and Carpenter J.F. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J. Pharm. Sci. 85 (1996) 1325-1330
56. Webb S.D., Cleland J.L., Carpenter J.F., and Randolph T.W. Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-γ. J. Pharm. Sci. 92 (2003) 715-729